Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi crawled date : 2021 - 03 - 15 save search
Bullous Pemphigoid Market is Expected to Grow With a CAGR of 16.27% for the Study Period of 2018-2030, says DelveInsight
Published: 2021-03-15 (Crawled : 17:00) - prnewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results...
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Global Meningococcal Vaccines Disease Coverage Forecast and Market Analysis to 2024: Assessment, Future Trends, Unmet Needs, Marketed Vaccines
Published: 2021-03-15 (Crawled : 15:00) - prnewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
disease vaccine
Sanofi and Regeneron Halt Cervical Cancer Trial Early Due to Dazzling Results, Plan to Submit to ...
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
results cancer trial
Clinical Catch-Up: March 8-12
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Aiforia appoints Swedbank as lead advisor to explore financing options
Published: 2021-03-15 (Crawled : 09:00) - prnewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
REGN | News | $910.71 1.17% 150K
|
Health Technology
|
| O: 0.33%
H: 2.47%
C: 2.31%
positive therapy cancer phase 3 trial
Danone: New governance at Danone; Emmanuel Faber steps down as Chairman and CEO Gilles Schnepp appointed non-executive Chairman
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $47.72 1.21% 1.1M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
ceo
Gainers vs Losers
| 86% | 14% |
Top 10 Gainers
MTTR | News M | $4.56 162.07% 21M
|
AGBA | $2.74 119.2% 52M
|
Finance
CZOO | $9.07 81.76% 22M
|
EDBL | News | $6.56 74.47% 1.8M
|
MTC | $2.21 41.67% 5.6M
|
Technology Services
OPRT | News | $3.12 38.67% 11M
|
Finance
PALI | $6.59 33.67% 23M
|
Manufacturing
VNRX | $0.7989 33.15% 3.2M
|
Health Technology
BTCM | $3.51 30.0% 730K
|
Arts, Entertainment, and Recrea...
MLEC | $1.81 29.29% 2.8M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.